Simplified human immunodeficiency virus maintenance therapy in virologically suppressed children with ritonavir-boosted protease inhibitor monotherapy

Pediatric Infectious Disease Journal

Volumn 30, Issue 10, 2011, Pages 917-

  Neth, Olaf ^a   Falcon Neyra, Lola ^a   Ruiz Valderas, Rosa ^a   León Leal, Jose Antonio ^a   Obando, Ignacio ^a   Alvarez Del Vayo Benito, Concepción ^a   Lopez Cortes, Luis F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; LOPINAVIR; RITONAVIR; VIRUS RNA;

CD4 LYMPHOCYTE COUNT; CHILD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAINTENANCE THERAPY; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS LOAD; VIRUS RESISTANCE;

EID: 80052957976     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318223bc56     Document Type: Letter

References (5)

1. Kim RJ, Rutstein RM. Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients. Paediatr Drugs. 2010;12:187-199.
2. Pulido F, Matarranz M, Rodríguez-Rivera V, et al. Boosted protease inhibitor monotherapy. What have we learnt after seven years of research? AIDS Rev. 2010;12:127-134.
3. Bunupuradah T, Kosalaraksa P, Puthanakit T, et al. HIV-NAT 077 Study Team. Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children. AIDS. 2011;25:315-323.
4. Mur-Sierra A, López-Segura N, López-Vílchez MA. Simplification to lopinavir/ritonavir mono-therapy in HIV-infected children [in Spanish]. An Pediatr (Barc). In press. An Pediatr (Barc). 2011 Mar 23. [Epub ahead of print].
5. Deeks SG. HIV infection, inflammation, immu-nosenescence, and aging. Annu Rev Med. 2011; 62:141-155.